TETRACYCLINE INDUCTION OF NATURAL DRUG RESISTANCE TO BEDAQUILINE IN <I>MYCOBACTERIUM SMEGMATIS</I> MC2 155 ArticleVatlin A.A., Tsybizov D.A., Letvinova V.S., Danilenko V.N.Russian Journal of Genetics. Том 60. 2024. С. 1437-1440
SYNTHESIS AND CHARACTERIZATION OF NOVEL 2-ACYL-3-TRIFLUOROMETHYLQUINOXALINE 1,4-DIOXIDES AS POTENTIAL ANTIMICROBIAL AGENTS ArticleBuravchenko G.I., Maslov D.A., Alam M.S., Grammatikova N.E., Frolova S.G., Vatlin A.A., Tian X., Ivanov I.V., Bekker O.B., Kryakvin M.A., Dontsova O.A., Danilenko V.N., Zhang T., Shchekotikhin A.E.Pharmaceuticals. Том 15. 2022.
REPURPOSING BASED IDENTIFICATION OF NOVEL INHIBITORS AGAINST MMPS5-MMPL5 EFFLUX PUMP OF MYCOBACTERIUM SMEGMATIS: A COMBINED IN SILICO AND IN VITRO STUDY ArticleShahbaaz M., Maslov D.A., Vatlin A.A., Danilenko V.N., Grishina M., Christoffels A.Biomedicines. Том 10. 2022.
TRANSCRIPTOMIC PROFILE OF MYCOBACTERIUM SMEGMATIS IN RESPONSE TO AN IMIDAZO[1,2-B][1,2,4,5]TETRAZINE REVEALS ITS POSSIBLE IMPACT ON IRON METABOLISM ArticleVatlin A.A., Shitikov E.A., Shahbaaz M., Bespiatykh D.A., Klimina K.M., Christoffels A., Danilenko V.N., Maslov D.A.Frontiers in Microbiology. Том 12. 2021.
